These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18642108)

  • 1. Interferon-gamma and granulocyte-macrophage colony stimulating factor therapy in three patients with pulmonary aspergillosis.
    Bandera A; Trabattoni D; Ferrario G; Cesari M; Franzetti F; Clerici M; Gori A
    Infection; 2008 Aug; 36(4):368-73. PubMed ID: 18642108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony-stimulating factor or interferon-gamma.
    Hrubec TC; Yan M; Ye K; Salafia CM; Holladay SD
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Dec; 288(12):1303-9. PubMed ID: 17075842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culture of human monocytes with granulocyte-macrophage colony-stimulating factor results in enhancement of IFN-gamma receptors but suppression of IFN-gamma-induced expression of the gene IP-10.
    Finbloom DS; Larner AC; Nakagawa Y; Hoover DL
    J Immunol; 1993 Mar; 150(6):2383-90. PubMed ID: 8450219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma therapy in two patients with progressive chronic pulmonary aspergillosis.
    Kelleher P; Goodsall A; Mulgirigama A; Kunst H; Henderson DC; Wilson R; Newman-Taylor A; Levin M
    Eur Respir J; 2006 Jun; 27(6):1307-10. PubMed ID: 16772392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.
    Gaviria JM; van Burik JA; Dale DC; Root RK; Liles WC
    J Infect Dis; 1999 Apr; 179(4):1038-41. PubMed ID: 10068606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
    Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
    J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal haemoptysis associated with invasive pulmonary aspergillosis treated with high-dose amphotericin B and granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Groll A; Renz S; Gerein V; Schwabe D; Katschan G; Schneider M; Hübner K; Kornhuber B
    Mycoses; 1992; 35(3-4):67-75. PubMed ID: 1435849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-macrophage colony-stimulating factor and interferon-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae.
    Roilides E; Blake C; Holmes A; Pizzo PA; Walsh TJ
    J Med Vet Mycol; 1996; 34(1):63-9. PubMed ID: 8786473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children.
    Abzug MJ; Walsh TJ
    Pediatr Infect Dis J; 2004 Aug; 23(8):769-73. PubMed ID: 15295229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of adjuvant granulocyte-macrophage colony-stimulating factor in HIV-related disseminated atypical mycobacterial infection.
    de Silva TI; Cope A; Goepel J; Greig JM
    J Infect; 2007 Apr; 54(4):e207-10. PubMed ID: 17197031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal immunity and adjuvant cytokine immune enhancement in cancer patients with invasive fungal infections.
    Safdar A
    Clin Microbiol Infect; 2007 Jan; 13(1):1-4. PubMed ID: 17184281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
    Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy in patients with systemic mycoses: a promising adjunct.
    Farmaki E; Roilides E
    BioDrugs; 2001; 15(4):207-14. PubMed ID: 11437686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunostimulation by complete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, or interferon-gamma reduces severity of diabetic embryopathy in ICR mice.
    Punareewattana K; Holladay SD
    Birth Defects Res A Clin Mol Teratol; 2004 Jan; 70(1):20-7. PubMed ID: 14745891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-mediated side-effects of cytokines in humans.
    Vial T; Descotes J
    Toxicology; 1995 Dec; 105(1):31-57. PubMed ID: 8638283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia.
    Dignani MC; Rex JH; Chan KW; Dow G; deMagalhaes-Silverman M; Maddox A; Walsh T; Anaissie E
    Cancer; 2005 Jul; 104(1):199-204. PubMed ID: 15929126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-gamma in patients with inoperable hepatocellular carcinoma.
    Reinisch W; Holub M; Katz A; Herneth A; Lichtenberger C; Schoniger-Hekele M; Waldhoer T; Oberhuber G; Ferenci P; Gangl A; Mueller C
    J Immunother; 2002; 25(6):489-99. PubMed ID: 12439346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.